• share
• favorite_border

The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System a five-year, $2.9-million grant to launch a new center, one of only 8 in the country, for diabetes translation research. The center—the New York Regional Center for Diabetes Translation Research (NY Regional CDTR)—also includes faculty from the Icahn School of Medicine at Mt. Sinai and the New York Academy of Medicine.

• share
• favorite_border

Falls are the leading cause of fatal and non-fatal injuries among older Americans and all too often lead to physical decline and loss of independence. Now, researchers at Albert Einstein College of Medicine have found that measuring the brain activity of healthy older adults while they’re walking and talking can predict their risk of falling. Their research is published today in the online issue of Neurology®, the medical journal of the American Academy of Neurology.

• share
• favorite_border

December 1, 2016 — (BRONX, NY) —The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine and Pennsylvania State University a five-year, $12.2 million grant to continue studies on the aging brain, Alzheimer’s disease and other dementias. More than five million Americans are living with Alzheimer’s disease—a number that is expected to double by 2040 as baby boomers age.

• share
• favorite_border

The National Institutes of Health (NIH) has awarded Bernice Morrow, Ph.D., at Albert Einstein College of Medicine and collaborators at the Children’s Hospital of Philadelphia (CHOP) a five-year, $7.5 million grant to study the genetics of congenital heart abnormalities.

• share
• favorite_border

Researchers, led by Steven Almo, Ph.D., and Chandan Guha, M.B.B.S., Ph.D., at Albert Einstein College of Medicine have received a five-year, $2.6 million NIH grant to make immunotherapy agents that are more precise and effective at treating various types of cancers.

• share
• favorite_border

A study published online today in Nature by Albert Einstein College of Medicine scientists suggests that it may not be possible to extend the human life span beyond the ages already attained by the oldest people on record.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine have received a five-year, $3.9 million National Institutes of Health grant to investigate the role of the gut microbiome in the development of type 2 diabetes among Hispanics/Latinos, the fastest-growing segment of the U.S. population. Hispanics in the U.S. have a 66 percent higher rate of diabetes than non-Hispanic whites (11.8 percent versus 7.1 percent). Since therapies can alter the microbiome in the gut, the research could lead to strategies for preventing and treating diabetes. Einstein co-principal investigators on the grant are Robert C. Kaplan, Ph.D., and Robert D. Burk, M.D., Rob Knight, Ph.D. at University of California San Diego is also a co-principal investigator.

• share
• favorite_border

In research published in Science, a team of scientists describe a new therapeutic strategy to target a hidden Achilles’ heel shared by all known types of Ebola virus. Two antibodies developed with this strategy blocked the invasion of human cells by all five ebolaviruses. The team included scientists from Albert Einstein College of Medicine, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Integrated Biotherapeutics, Vanderbilt University Medical Center, and The Scripps Research Institute.

• share
• favorite_border

Tuberculosis (TB) is the leading cause of death worldwide among people infected with HIV. But as yet, no test can reliably show when latent (inactive) TB infections in people with HIV starts progressing to active—and potentially fatal—TB disease. Now, a researcher at Albert Einstein College of Medicine has received a five-year, $3.7 million National Institutes of Health grant to identify biomarkers that signal an increase in activity by Mycobacterium tuberculosis (Mtb), the bacterium that causes TB, in people with HIV.

• share
• favorite_border

Albert Einstein College of Medicine and Montefiore, in collaboration with the City University of New York (CUNY), have received a $9.4 million grant from the National Institutes of Health (NIH) to lead research in Central Africa to improve clinical care and health outcomes for patients with HIV. The ongoing, five-country observational study, called Central Africa International Epidemiologic Databases to Evaluate AIDS (CA-IeDEA), involves more than 50,000 HIV-positive children and adults taking anti-retroviral therapy (ART).

• share
• favorite_border

More than one-third of Bronx residents are born outside of the United States. Often separated from family, challenged by language barriers, unfamiliar with health resources, and burdened by poverty, they are at high risk for health problems. And these risks extend to their young children.

• share
• favorite_border

In a study of nearly 3,000 people, Einstein researchers have found that those who live 95 years or more are able to stave off age-related disease, with serious sickness compressed into only a few years late in life.

• share
• favorite_border

Cristina Gonzalez, M.D., M.Ed., associate professor of clinical medicine at Albert Einstein College of Medicine and attending physician at Montefiore, has been selected as a 2016 Macy Faculty Scholar. One of only five chosen nationally, Dr. Gonzalez will receive a $100,000 grant from the Josiah Macy Jr. Foundation to allow her to pursue her medical education research and curriculum development.

• share
• favorite_border

Researchers, led by Michael Lipton, M.D., Ph.D., at Albert Einstein College of Medicine and Montefiore Health System, using an advanced imaging technique, have been able to predict which patients who’d recently suffered concussions were likely to fully recover.

• share
• favorite_border

Many young adults with abdominal obesity exhibit a readily detectable risk factor for chronic kidney disease (CKD), yet the vast majority don’t know they’re at risk, according to a study of nationwide health data led by Albert Einstein College of Medicine researchers that was published online today in the journal PLOS ONE.

• share
• favorite_border

Albert Einstein College of Medicine has named Kamran Khodakhah, Ph.D. chair of the Dominick P. Purpura Department of Neuroscience . Dr. Khodakhah, who has been interim chair of the department since 2013, will assume his new role on [Month Day], 2016.

• share
• favorite_border

For the first time, scientists at Albert Einstein College of Medicine have developed a technology allowing them to “see” single molecules of messenger RNA as they are translated into proteins in living mammalian cells. Initial findings using this technology that may shed light on neurological diseases as well as cancer were published online today in Science.

• share
• favorite_border

Luciano D’Adamio, M.D., Ph.D., professor of microbiology & immunology at Albert Einstein College of Medicine, has received a five-year, $3.6-million grant from the National Institutes of Health to continue his research into how APP is processed in the brain.

• share
• favorite_border

Juvenile idiopathic arthritis, or JIA, is the most common form of childhood arthritis. It appears to be an autoimmune disease, caused by antibodies attacking certain proteins in a person’s own tissue. But no “autoantigens”—the proteins triggering an immune attack—have been linked to JIA.

• share
• favorite_border

Headlines about America’s worsening drug epidemic have focused on deaths from opioids—heroin and prescription painkillers such as OxyContin. But overdose deaths have also soared among the millions of Americans using benzodiazepine drugs, a class of sedatives that includes Xanax, Valium, and Klonopin, according to a study led by researchers at Albert Einstein College of Medicine, Montefiore Health System and the Perelman School of Medicine at University of Pennsylvania. Their findings appear online today in the American Journal of Public Health.